Newsfeeds - Spark Newswire

4 minute read

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More

Today, 4:02 AM

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

ADMP

1 minute read

Earnings

Iterum Therapeutics Earnings Preview

By Benzinga Insights

Today, 4:02 AM

Iterum Therapeutics (NASDAQ:ITRM) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement. Analysts estimate that Iterum Therapeutics will report an earnings per share (EPS) of $-0.04.

ITRM

1 minute read

Earnings

Iterum Therapeutics Q4 2021 Earnings Conference Call On March 28, 2022 At 08:30 AM ET

By Benzinga Insights

Today, 4:02 AM

Iterum Therapeutics (NASDAQ:ITRM) will host a conference call at 08:30 AM ET on March 28, 2022, to discuss Q4 2021 earnings results.

ITRM

2 minute read

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

Today, 4:02 AM

AERI

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 4:02 AM

Gainers Cognition Therapeutics (NASDAQ:CGTX) shares rose 14.9% to $6.62 during Wednesday's after-market session. The market value of their outstanding shares is at $145.8 million.

BFRI

4 minute read

Earnings Scheduled For November 12, 2021

By Benzinga Insights

Today, 4:02 AM

Companies Reporting Before The Bell • Zevia (NYSE:ZVIA) is estimated to report quarterly loss at $0.43 per share on revenue of $34.40 million.

AZN

2 minute read

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

Today, 4:02 AM

AXLA

5 minute read

54 Biggest Movers From Friday

By Lisa Levin

Today, 4:02 AM

Gainers

ADGI

3 minute read

35 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 4:02 AM

Gainers Biomerica, Inc. (NASDAQ: BMRA) shares climbed 38.3% to $6.23. Biomerica entered into a Supplier Agreement with Walmart to sell its EZ Detect colorectal disease screening test within the Walmart retail system.

ADGI

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

Today, 4:02 AM

Gainers Biomerica (NASDAQ:BMRA) stock increased by 43.11% to $6.44 during Friday's pre-market session. The market value of their outstanding shares is at $80.5 million.

ADGI